Back to results
US 10,655,156 B2Granted
Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
AssigneeAmgen Inc.
InventorsShivani Gupta, Sohye Kang
Life of this patent
Estimating the term…
Abstract
Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the overexpression of proteins involved in the N-glycosylation pathway.
Claims21
A method of decreasing the high mannose glycoform content of a recombinant protein during a mammalian cell culture process, compared to a culture in which mammalian cells are not subject to a transfection to overexpress proteins involved in N-glycosylation, the method comprising:
- transfecting a mammalian host cell to overexpress a protein that is involved in an N-glycosylation pathway, wherein the protein involved in the N-glycosylation pathway is selected from the group consisting of N-acetyl-glucosaminyltransferase-1 (encoded by Mgat1);
- N-acetyl-glucosaminyltransferase-2 (encoded by Mgat2);
- a UDP-Galactose transporter encoded by Slc35a2;
- and combinations thereof;
- growing the transfected mammalian host cell, thereby producing transfected mammalian host cells;
- and
- either
- (a) subjecting the transfected mammalian host cells to a temperature shift;
- or
- (b) inducing the transfected mammalian host cells into cell growth arrest by L-asparagine starvation followed by perfusion with a serum-free perfusion media having an L-asparagine concentration of 5 mM or less,
- whereby said high mannose glycoform content of the recombinant protein is decreased.
8 more elements
Dependencies are inferred from the claim text.